Company profile
Bluejay Diagnostics, Inc.
NASDAQ: BJDX · Healthcare · Medical - Devices
PublicHQ Acton, MACIK 0001704287Reports USD
#987 of 1,418 Healthcare companies by revenue
EA Score
33DFH 34DQ 33GM —SS 22
v0.1 · 55/100 weight · provisional
↑ balance-sheet leverage, filing timeliness · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$6.8M
Employees
6
as of 2026-08-27
Market cap
$928.4k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$249.0k$249.0k2022
Net income-$6.8M-$6.8M2025
Operating income-$7.0M-$7.0M2025
Total assets$7.1M$7.1M2025
Liabilities$1.1M$1.1M2025
Equity$6.0M$6.0M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bluejay Diagnostics, Inc.’s revenue?
Bluejay Diagnostics, Inc. booked $249.0k in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -2750.0% net margin.
Peers · Healthcare
Savara Inc.50DNexteligent Holdings, Inc.46DAdhera Therapeutics Inc——Envoy Medical, Inc.33DWellness Center USA, Inc.——LiveWire Ergogenics, Inc.——Key facts
CEOIndranil Dey
SectorHealthcare
IndustryMedical - Devices
HeadquartersActon, MA
ExchangeNASDAQ: BJDX
Employees6
IPO date2021-11-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.